期刊文献+

乙肝肝硬化患者FIB-4指数与Child-Pugh分级相关性研究 被引量:3

The Correlation of FIB-4 Index with Child-Pugh Classification in Patients with HBV-related Cirrhosis
在线阅读 下载PDF
导出
摘要 目的:探讨乙肝肝硬化患者FIB-4指数与Child-Pugh分级之间的相关性,了解其评估乙肝肝硬化患者病情严重程度及预后的能力。方法:回顾性分析112例乙肝肝硬化住院患者,按Child-Pugh分级分为A、B、C三组,根据患者年龄、ALT、AST及血小板计数计算其FIB-4指数,评估各组间FIB-4指数差异性,并采用Spearman's等级相关性分析研究FIB-4指数与Child-Pugh分级之间的关系。结果:乙肝肝硬化患者按Child-Pugh分级分组后比较3组间FIB-4指数差异均有统计学意义(P<0.01);患者FIB-4指数与Child-Pugh分级呈显著正相关(r=0.817,P<0.01)。结论:乙肝肝硬化患者FIB-4指数与Child-Pugh分级之间呈正相关,FIB-4指数测定可作为客观评估乙肝肝硬化患者病情严重程度及预后的有效工具。 Objective To investigate the correlation between FIB-4 index and Child-Pugh classification in patients with HBVrelated cirrhosis.Methods The clinical data of 112 patients with HBV-related cirrhosis were restrospectively analyzed.The patients were divided into three groups(group A,B,C) according to Child-Pugh classification.FIB-4 index were calculated based on age,levels of ALT and AST,platelet counts.The Spearman's rank correlation was used to analyze the relationship between FIB-4 index and Child-Pugh classification.Results There was a significant difference in the FIB-4 index among group A,B and C(all P < 0.01).The Spearman's rank correlation analysis demonstrated that the coefficient correlation between FIB-4 index and Child-Pugh classification was 0.817(P < 0.01).Conclusion The FIB-4 index is closely correlated to Child-Pugh classification in patients with HBV-related cirrhosis.The FIB-4 index is a simple,objective and effective method for assessing the severity and prognosis of patients with HBV-related cirrhosis.
出处 《湖北医药学院学报》 CAS 2013年第3期245-247,共3页 Journal of Hubei University of Medicine
关键词 FIB-4指数 Chlid-Pugh分级 肝硬化 FIB-4 index Child-Pugh classification Liver cirrhosis
  • 相关文献

参考文献11

  • 1刘伟,郑军,邢荣春,赵延春.肝脏储备功能评估及临床应用的研究进展[J].中国普通外科杂志,2012,21(1):103-107. 被引量:3
  • 2V Mallet,V Dhalluin-Venier,C Roussin.The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B[].Alimentary Pharmacology and Therapeutics.2009
  • 3Cholongitas E,Papatheodoridis GV,Vangeli M,et al.Systematic review:The model for end-stage liver dis-ease--should it replace Child-Pugh’’s classification forassessing prognosis in cirrhosis?[].Aliment Pharma-col Ther.2005
  • 4Baranova A,Lal P,Birerdinc A,et al.Non-invasive markers for he-patic fibrosis[].BMC Gastroenterology.2011
  • 5Trang T,Petersen JR,Snyder N.Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV:comparison of the APRI and FIB-4 index[].Clinica Chimica Acta.2008
  • 6Kamath PS,Kim WR.The Model for End-Stage Liver Disease(MELD)[].Hepatology.2007
  • 7Vallet-Pichard A,Mallet V,Pol S.FIB-4:a simple,inexpensive andaccurate marker of fibrosis in HCV-infected patients[].Hepatology.2006
  • 8Vallet-Pichard A,Mallet V,Nalpas B,et al.FIB-4:aninexpensive and accurate marker of fibrosis in HCV in-fection.comparison with liver biopsy and fibrotest[].Hepatology.2007
  • 9Sterling RK,Lissen E,Clumeck N,et al.Developmentof a simple noninvasive index to predict significant fi-brosis in patients with HIV/HCV coinfection[].Hepatology.2006
  • 10KH Han,KT Yoon.New diagnostic method for liver fibrosis and cirrhosis[].Intervirology.2008

二级参考文献33

  • 1Child llI CG, Turcotte JG. Surgery and portal Hypertension[A]. In: Child III CG (Ed). The Liver And Portal Hypertension[M]. Philadelphia: Saunder, 1964:50.
  • 2Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal variees[J]. Br J Surg, 1973, 60(8):646-649.
  • 3Triantos C, Zisimopoulos K, Tsochatzis E, et al. Meld vs cps for prognosis in cirrhosis. Results from a multicentre study[J]. J Hepatol, 2010, 52:S89.
  • 4Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, et al. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation [J].Transplant Proc, 2009, 41(8): 3114-3116.
  • 5Gitto S, Biselli M, Gramenzi A, et al. A modified child-turcottepugh(CTP)for selection of patients affected by cirrhosis candidates to fiver transplantation(LT) with low model for end-stage liver disease score (MELD)[J]. J Hepatol, 2010, 52:S315.
  • 6Eric H, Lau WY, Darren VM Selection of Patients for Liver Resection[A]. In: Lau WY. ttepatocellular carcinoma[M]. World Scientific Publishing Co. Pte Ltd, 2008:303 -315.
  • 7Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation[J]. N Engl J Med, 2007, 356(15):1545-1559.
  • 8Makuuchi M, Kosuqe T, Takayama T, et al. Surgery for small liver cancers[J]. Semin Surg Oncol, 1993, 9(4):298-304.
  • 9Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31 (4): 864-871.
  • 10Kamath PS, Wiesner RH, Malinchoc M, et al.A model to predict survival in patientswith end-stage liver disease[J]. Hepatology 2001,33(2):464-470.

共引文献2

同被引文献20

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部